Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose lithium for children with autism
ChiCTR2000040336Phase 2Not yet recruiting
- Sponsor
- The Third Affiliated Hospital of Zhengzhou University
- Start
- Dec 2020
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of lithium carbonate in Autism Spectrum Disorder (ASD) (2 arms), sponsored by The Third Affiliated Hospital of Zhengzhou University. Primary endpoint: Autism Treatment Evaluation Checklist (ATEC). Planned start Dec 2020; status: not yet recruiting.
02
Drugs
lithium carbonate
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on ChiCTR2000040336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040336.